Corvus Pharmaceuticals
Stock Forecast, Prediction & Price Target
Corvus Pharmaceuticals (CRVS) stock Price Target by analysts
$12.5
Potential upside: 143.19%
Corvus Pharmaceuticals price prediction
What is Corvus Pharmaceuticals stock analysts` prediction?
Corvus Pharmaceuticals stock forecast: Based on 2 Wall Street analysts` predicted price targets for Corvus Pharmaceuticals in the last 3 months, the avarage price target is $12.5, with a high forecast of $NaN. The average price target represents a 143.19% change from the last price of $5.14.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Corvus Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given Corvus Pharmaceuticals price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Roger Song Jefferies | 0% 0/1 | 11 months ago | $13 152.91% upside | $3.97 | StreetInsider | Previous targets (0) |
Graig Suvannavejh Mizuho Securities | 0% 0/1 | 11 months ago | $12 133.46% upside | $7.56 | StreetInsider | Previous targets (0) |
Jeff Jones Oppenheimer | 0% 0/1 | about 2 years ago | $7 36.18% upside | $2.19 | Benzinga | Previous targets (0) |
Corvus Pharmaceuticals Financial Estimates
Corvus Pharmaceuticals Revenue Estimates
Corvus Pharmaceuticals EBITDA Estimates
Corvus Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $16.9M Low: $16.9M High: $16.9M avg. 0% | Avg: $6.71M Low: $6.71M High: $6.71M avg. -60.25% | Avg: $36.26M Low: $36.26M High: $36.26M avg. 439.92% | Avg: $96.23M Low: $96.23M High: $96.23M avg. 165.33% |
Net Income
% change YoY
| $-38.2M N/A | $-50.04M -31.01% | $-27.02M 45.99% | Avg: $-45.74M Low: $-36.01M High: $-18.24M avg. -69.23% | Avg: $-55.65M Low: $-40.82M High: $-17.76M avg. -21.66% | Avg: $-25.33M Low: $-25.33M High: $-25.33M avg. 54.47% | Avg: $-11.76M Low: $-11.76M High: $-11.76M avg. 53.55% |
EBITDA
% change YoY
| $-43.22M N/A | $-32.58M 24.61% | $-26.87M 17.51% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.91 N/A | -$1.08 -18.68% | -$0.56 48.14% | Avg: -$0.55 Low: -$0.75 High: -$0.38 avg. 2.67% | Avg: -$0.64 Low: -$0.85 High: -$0.37 avg. -17.43% | Avg: -$0.53 Low: -$0.53 High: -$0.53 avg. 17.57% | Avg: -$0.25 Low: -$0.25 High: -$0.25 avg. 53.55% |
Operating Expenses
% change YoY
| $38.63M N/A | $32.56M -15.70% | $23.40M -28.12% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Corvus Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 4.28% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -36.01M, average is -45.74M and high is -18.24M.
What is Corvus Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 136.25% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $16.9M, average is $16.9M and high is $16.9M.
What is Corvus Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 14.09% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.75, average is -$0.55 and high is $-0.38.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Corvus Pharmaceuticals stock. The most successful analyst is Roger Song.